Affordable Access

Publisher Website

A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of avanafil in subjects with erectile dysfunction.

Authors
Type
Published Article
Journal
Journal of Sexual Medicine
1743-6109
Publisher
Elsevier
Publication Date
Volume
9
Issue
4
Pages
1122–1133
Identifiers
DOI: 10.1111/j.1743-6109.2011.02629.x
PMID: 22248153
Source
Medline

Abstract

Following 12 weeks of avanafil treatment without food or alcohol restrictions, significant improvements in sexual function were observed with all 3 doses of avanafil compared with placebo. Successful intercourse was observed as early as 15 minutes and >6 hours after dosing in some subjects. Avanafil was generally well tolerated for the treatment of ED.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments